Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine

Overview of attention for article published in International Journal of Retina and Vitreous , August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#7 of 210)
High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog

twitter: 11 tweeters

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 46 Mendeley

Summary News Blogs Twitter Dimensions citations

So far, Dimensions has found 23 publications that cite this research output.

23

The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.

Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine

Article in Frontiers in Immunology (September 2022)

Possible Association between Vogt-Koyanagi-Harada Disease and Coronavirus Disease Vaccine: A Report of Four Cases.

Article in Ocular Immunology and Inflammation (August 2022)

De novo Vogt-Koyanagi-Harada disease after vaccination for COVID-19, successfully treated with systemic steroid therapy and monitored with laser speckle flowgraphy

Article in American Journal of Ophthalmology Case Reports (June 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.